The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Mer­ck part­ner Arti­va blue­prints San Diego R&D, man­u­fac­tur­ing site to take NK cell op­er­a­tion to the next lev­el

4 years ago
Cell/Gene Tx

Out to re­vamp plant-based drug man­u­fac­tur­ing, An­theia locks in part­ner­ship with syn­thet­ic bi­ol­o­gy gi­ant Gink­go

4 years ago
Deals

Heat Bi­o­log­ics goes back to San An­to­nio to build a re­search and man­u­fac­tur­ing fa­cil­i­ty

4 years ago
R&D

Mod­er­na strikes a deal with Cana­da to build an mR­NA man­u­fac­tur­ing cen­ter — and it’s look­ing for more glob­al pacts just like it

4 years ago
Coronavirus

Bi­o­Life So­lu­tions sets up shop in In­di­anapo­lis, adding a slate of new cell and gene ther­a­py tools to its belt

4 years ago
Deals
Cell/Gene Tx

FDA shoots down Spec­trum's neu­trope­nia drug, cit­ing man­u­fac­tur­ing is­sues

4 years ago
FDA+

Room tem­per­a­ture ther­a­pies and bi­o­log­ics stored with lunch: New York drug im­porter hand­ed FDA warn­ing let­ter

4 years ago

Q&A: BeiGene ex­ec re­flects on path that led them to se­lect NJ for a ma­jor man­u­fac­tur­ing/R&D cam­pus

4 years ago

A Texas-based phar­ma has en­list­ed Catal­ent for oral sol­id man­u­fac­tur­ing; Cy­ti­va drops mas­sive man­u­fac­tur­ing in­vest­ment in home state

4 years ago

Am­gen adds new NC plant to the list as part of $1B man­u­fac­tur­ing ex­pan­sion plans state­side

4 years ago

Fast-grow­ing BeiGene blue­prints 42-acre R&D and man­u­fac­tur­ing cam­pus in the US, with plans to hire 'hun­dred­s'

4 years ago
R&D

To fill African man­u­fac­tur­ing void, BioN­Tech will pig­gy­back off plans for malar­ia mR­NA vac­cine with new man­u­fac­tur­ing sites

4 years ago

In a win for strug­gling na­tion­s' vac­cine sup­ply, first African-pro­duced dos­es of J&J shot hit arms

4 years ago
Coronavirus

Ther­mo Fish­er con­tin­ues its hot streak, but a dip in di­ag­nos­tics sales could be trou­ble

4 years ago

Charles Riv­er to ex­pand Ire­land man­u­fac­tur­ing site to add Covid-19 vac­cine ca­pac­i­ty

4 years ago
Coronavirus

Take­da dou­bles down at Cal­i­for­nia site as it looks to grow rare dis­ease man­u­fac­tur­ing base

4 years ago

Re­silience shells out $110M for blue­bird bio site, kick­start­ing new col­lab­o­ra­tion

4 years ago

Af­ter a months-long halt on pro­duc­tion, Emer­gent is back up and run­ning in Bal­ti­more

4 years ago
Coronavirus

Covid-19 man­u­fac­tur­ing roundup: Top diplo­mat calls for low-cost, over­seas pro­duc­tion of shots; Viet­nam inks deal for Japan­ese vac­cine tech trans­fer

4 years ago
Coronavirus

BioN­Tech is spear­head­ing an mR­NA vac­cine de­vel­op­ment pro­gram for malar­ia, with a tech trans­fer planned for Africa

4 years ago
R&D

Seat­tle's Lu­men will move in­to new head­quar­ters in for­mer long-lived bak­ery amid tri­al ex­pan­sion

4 years ago

US gov­ern­ment drops $200M in­to South African man­u­fac­tur­ing op­er­a­tion for Covid-19 vac­cines

4 years ago
Coronavirus

Re­ci­pharm to con­struct new In­di­an fill-fin­ish fa­cil­i­ty as part of ex­ist­ing re­la­tion­ship with Nichep­harm found­ing fam­i­ly'

4 years ago
Outsourcing

Covid-19 man­u­fac­tur­ing roundup: Mod­er­na inks deal for boost­er shots with Japan; Sput­nik Light could be man­u­fac­tured in Kaza­khstan — re­port

4 years ago
Coronavirus
First page Previous page 67686970717273 Next page Last page
A service from the Financial Times